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INTRODUCTION
As the opioid crisis in America continues,
opioid use in pregnancy increases. As a
result, more babies are exposed to opiates
prenatally and are at risk for developing
neonatal abstinence syndrome. According
to the CDC, the overall rate of NAS
diagnoses increased 300% from 1999 to
2013 (Cook & Fantasia, 2019). Effective
treatment of neonatal abstinence syndrome
is more necessary than ever.

LITERATURE REVIEW
Methods
● Key Terms: Methadone, “Neonatal Abstinence
Syndrome,” “Eat, sleep, console,” NAS
● Criteria: Published in the last 5 years, had to
discuss neonatal abstinence syndrome
● Databases: CINAHL and JOGNN

Eat, Sleep, Console (Grossmann et al., 2018)
● Focuses on the ability of the infant to function
● Does not require the infant to be disturbed
● Treatment is adjusted if withdrawal severe
enough to interfere with the infant’s ability to
function well and/or be consoled occurs
● Indications of positive treatment outcomes
according to the ESC model:
○ Take at least 1 ounce per feeding or
breastfeed adequately
○ Sleep undisturbed for at least 1 hour
○ Can be consoled within 10 minutes when
crying

RESULTS

CONCLUSIONS

The American Academy of Pediatrics’ (AAP)
Report on NAS recommends a 2-tiered
approach to treatment (Grossman et al., 2018)
● First-line therapy focus on nonpharmacologic
interventions
○ Swaddling
○ On-demand feedings
○ Low stim environments
● Second-line initiates opioid and adjuvant
medications only when nonpharmacologic
measures fail

Several approaches are used to treat NAS,
however, no universal standard exists.
Supportive care methods such as Eat,
Sleep, Console are considered the first-line
of treatment but the use of opioids such as
methadone have been recommended for
treatment of infants with significant NAS.

PICO QUESTION
P: In neonates with neonatal abstinence
syndrome
I: How effective is eat , sleep, console model
C: Compared to methadone
O: In controlling withdrawal symptoms
T: During the postnatal period?

Finnegan Scoring Tool
While 95% of institutions use the Finnegan
Neonatal Abstinence Scoring System (FNASS) to
guide pharmacologic treatment, the scale has
recently been called into question due to its poor
psychometric properties (Grossman et al., 2018).

● The eat, sleep, console model is better
understood
by
parents
creating
opportunity for them to participate in
their newborns care
● Positive
outcomes
with
nonpharmacologic treatments provide
evidence that neonates with NAS can be
successfully managed outside of the
NICU setting

Methadone
● Significantly shorter duration of treatment
when compared to Morphine treatment plans
● Treatment with Methadone results in
○ Longer time intervals between medication
administration
■ Leading to less interruption of feeding,
bonding, and sleeping
■ Longer half-life can result in increased
difficulty titrating methadone compared
to medications that have a shorter
half-life

● The eat, sleep, and console method:
○ Decreases the length of stay in the
hospital
○ Decreases the use of pharmaceuticals
○ More effective in the treatment of
newborns with neonatal abstinence
syndrome

Source: Grossman et al., 2018

The
use
of
non-pharmacologic
interventions as first-line treatment has
been shown to improve NAS outcomes
significantly. There is a 30–68% reduction
in pharmacologic treatment and hospital
LOS, as well as significant reductions in
hospitalization costs (Wachman et al.,
2018).
Average
length of
stay 17.1
days

Eat,
Sleep,
Console

5.5 day
reduction
in length
of stay

● When non-pharmacologic measures are
unable to reduce withdrawal symptoms
pharmacologic interventions can be
initiated using the Finnegan Scoring
System
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